Evolus, Inc. (EOLS): Price and Financial Metrics


Evolus, Inc. (EOLS)

Today's Latest Price: $11.29 USD

0.12 (1.07%)

Updated Jan 17 12:00am

Add EOLS to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 213 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

EOLS Stock Summary

  • EOLS's went public 1.94 years ago, making it older than just 4.59% of listed US stocks we're tracking.
  • With a year-over-year growth in debt of 472.15%, Evolus Inc's debt growth rate surpasses 95.46% of about US stocks.
  • Revenue growth over the past 12 months for Evolus Inc comes in at 569.75%, a number that bests 98.82% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Evolus Inc are APHA, ADES, QD, JT, and NBEV.
  • Visit EOLS's SEC page to see the company's official filings. To visit the company's web site, go to www.evolus.com.
EOLS Daily Price Range
EOLS 52-Week Price Range

EOLS Stock Price Chart More Charts


EOLS Price/Volume Stats

Current price $11.29 52-week high $30.25
Prev. close $11.17 52-week low $10.31
Day low $11.14 Volume 685,100
Day high $11.73 Avg. volume 873,208
50-day MA $12.72 Dividend yield N/A
200-day MA $16.33 Market Cap 377.37M

Evolus, Inc. (EOLS) Company Bio


Evolus, Inc. provides medical aesthetic products for physicians and their patients in the United States. It offers DWP-450, an injectable 900 kilodalton botulinum toxin type A complex designed to address the needs of the facial aesthetics market. The company was founded in 2012 and is based in Irvine, California.





EOLS Latest News Stream


Event/Time News Detail
Loading, please wait...

EOLS Latest Social Stream


Loading social stream, please wait...

View Full EOLS Social Stream

EOLS Price Returns

1-mo -8.51%
3-mo -30.44%
6-mo -35.08%
1-year -29.35%
3-year N/A
5-year N/A
YTD -7.23%
2019 2.27%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6503 seconds.